AXSM / Axsome Therapeutics, Inc. 10-K - Annual Report - 10-K. 03-12 sec.gov Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) … AXSM: Axsome Therapeutics Inc - Stock Price, Quote ... - CNBC Get Axsome Therapeutics Inc (AXSM:NASDAQ) real-time stock quotes, news and financial information from CNBC.

Axsome Therapeutics, Inc. (AXSM) Stock Price, Quote ... Find the latest Axsome Therapeutics, Inc. (AXSM) stock quote, history, news and other vital information to help you with your stock trading and investing. Axsome Therapeutics, Inc. - AXSM - Stock Price Today - Zacks View Axsome Therapeutics, Inc. AXSM investment & stock information. Get the latest Axsome Therapeutics, Inc. AXSM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. AXSM | Axsome Therapeutics Inc. Analyst Estimates & Rating ... AXSM updated stock price target summary. Dow Jones, a News Corp company. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services.

Stock analysis for Axsome Therapeutics Inc (AXSM:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company 

Stock analysis for Axsome Therapeutics Inc (AXSM:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company  Stable Share Price: AXSM's share price has been volatile over the past 3 months. AXSM, NasdaqGM (Nasdaq Global Market), Yes, Common Stock, US, USD  Check out the latest ideas and forecasts on AXSOME THERAPEUTICS INC from our top authors — they AXSM: Massive short squeeze in Overcrowded stock. 17 Mar 2020 On Monday, shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) marked marked $42.94 per share versus a previous $61.24 closing price. ally in the technical patterns of the stock movements showed in stock charts.

AXSM | Complete Axsome Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Predict and forecast AXSM (Axsome Therapeutics Inc) plus see real-time data from other investors. Start making your PredictWallStreet stock market predictions today. ZYNE Stock Price, Forecast & News (Zynerba Pharmaceuticals) Here are some recent quotes from research analysts about Zynerba Pharmaceuticals stock: 1. According to Zacks Investment Research, "Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. PHAS - PhaseBio Pharmaceuticals Inc Stock quote - … Find real-time PHAS - PhaseBio Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. PHAS - PhaseBio Pharmaceuticals Inc Stock quote - CNNMoney.com Markets AXSM Stock | AXSOME THERAPEUTICS Stock Price Today ...

Apr 08, 2020 · Ladenburg Thalmann Financial Services Inc. raised its position in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) by 55.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 7,454 shares of the company’s stock after acquiring an …

Nov 10, 2019 · Axsome Therapeutics Inc. analyst estimates by MarketWatch. View AXSM revenue estimates and earnings estimates, as well as analyst recommendations. AXSM Stock Analysis: Price, Forecast, and News AXSM Stock Analysis Overview . What this means: Axsome Thera (AXSM) gets a very positive evaluation from InvestorsObserver's ranking system. An Overall Rank of 83 means that our comprehensive methodology rates Axsome Thera above 83% of stocks. Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and

AXSM Axsome Therapeutics, Inc. Stock Quote

Here are some recent quotes from research analysts about Zynerba Pharmaceuticals stock: 1. According to Zacks Investment Research, "Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. PHAS - PhaseBio Pharmaceuticals Inc Stock quote - … Find real-time PHAS - PhaseBio Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. PHAS - PhaseBio Pharmaceuticals Inc Stock quote - CNNMoney.com Markets AXSM Stock | AXSOME THERAPEUTICS Stock Price Today ... AXSM: Get the latest Axsome Therapeutics stock price and detailed information including AXSM news, historical charts and realtime prices. Axsome Therapeutics, Inc. Common Stock (AXSM) Price ... AXSM Axsome Therapeutics, Inc. Common Stock (AXSM) Price/Earnings & PEG Ratios. Axsome Therapeutics, Inc. Common Stock (AXSM) Price/Earnings & …

Stock Price Forecast for AXSM: Axsome Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next Axsome Therapeutics Stock Forecast: up to 125.026 USD ... Historical index on US Stock Market : C "Should I invest in Axsome Therapeutics stock?" "Should I trade "AXSM" stock today?" According to our live Forecast System, Axsome Therapeutics, Inc stock is an awesome long-term (1-year) investment*. "AXSM" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. AXSM Price Target | Axsome Therapeutics Stock Forecast ... See Axsome Therapeutics price target based on 4 analysts offering 12 month price targets for Axsome Therapeutics in the last 3 months. The average price target is $157.33 with a high forecast of $200.00 and a low forecast of $107.00. The average price target … AXSM - Axsome Therapeutics Inc Stock quote - CNNMoney.com Find real-time AXSM - Axsome Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.